Literature DB >> 22540962

Patient factors and glycaemic control--associations and explanatory power.

S Rogvi1, I Tapager, T P Almdal, M L Schiøtz, I Willaing.   

Abstract

AIMS: To investigate the association between glycaemic control and patient socio-demographics, activation level, diabetes-related distress, assessment of care, knowledge of target HbA(1c), and self-management behaviours, and to determine to what extent these factors explain the variance in HbA(1c) in a large Danish population of patients with Type 2 diabetes.
METHODS: Cross-sectional survey and record review of 2045 patients from a specialist diabetes clinic. Validated scales measured patient activation, self-management behaviours, diabetes-related emotional distress, and perceived care. The electronic patient record provided information about HbA(1c), medication, body mass index, and duration of diabetes. Data were analysed using multiple linear regression models with stepwise addition of covariates.
RESULTS: The response rate was 54% (n = 1081). Good glycaemic control was significantly associated with older age, higher education, higher patient activation, lower diabetes-related emotional distress, better diet and exercise behaviours, lower body mass index, shorter duration of disease and knowledge of HbA(1c) targets (P < 0.05 for all). Patient socio-demographics, behaviour; perceptions of care and diabetes distress accounted for 14% of the total variance in HbA(1c) levels (P = 0.0134), but the variance explained was higher for respondents treated with medications other than insulin.
CONCLUSIONS: Our study emphasizes the complex relationships between patient activation, distress and behaviour, specific treatment modalities and glycaemic control. Knowledge of treatment goals, achieving patient activation in coping with diabetes, and lowering disease-related emotional stress are important patient education goals. However, the large unexplained component of HbA(1c) variance highlights the need for more research to understand the mechanisms of glycaemic control.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540962     DOI: 10.1111/j.1464-5491.2012.03703.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  16 in total

Review 1.  The association between the measurement of adherence to anti-diabetes medicine and the HbA1c.

Authors:  Sheila A Doggrell; Servane Warot
Journal:  Int J Clin Pharm       Date:  2014-03-22

2.  Patient activation and treatment decision-making in the context of cancer: examining the contribution of informal caregivers' involvement.

Authors:  Chiara Acquati; Judith H Hibbard; Ellen Miller-Sonet; Anao Zhang; Elena Ionescu
Journal:  J Cancer Surviv       Date:  2021-09-12       Impact factor: 4.062

3.  Impact of a community-based approach to patient engagement in rural, low-income adults with type 2 diabetes.

Authors:  Lynn E Glenn; Michelle Nichols; Maithe Enriquez; Carolyn Jenkins
Journal:  Public Health Nurs       Date:  2019-12-13       Impact factor: 1.462

4.  Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study.

Authors:  Boon-How Chew; Noor-Hasliza Hassan; Mohd-Sidik Sherina
Journal:  Patient Prefer Adherence       Date:  2015-05-06       Impact factor: 2.711

5.  Longitudinal relationship between diabetes-specific emotional distress and follow-up HbA1c in adults with Type 1 diabetes mellitus.

Authors:  R B Strandberg; M Graue; T Wentzel-Larsen; M Peyrot; H B Thordarson; B Rokne
Journal:  Diabet Med       Date:  2015-05-18       Impact factor: 4.359

6.  Association between depression and glycemic control among type 2 diabetes patients in Lima, Peru.

Authors:  Brenda Crispín-Trebejo; María Cristina Robles-Cuadros; Antonio Bernabé-Ortiz
Journal:  Asia Pac Psychiatry       Date:  2015-06-02       Impact factor: 2.538

7.  Psychosocial Correlates of Diabetes Self-management Practices.

Authors:  Muhammad W Darawad; Sawsan Hammad; Sultan Mosleh; Osama A Samarkandi; Ayman Hamdan-Mansour; Amani A Khalil; Diana Arabiat
Journal:  Iran J Public Health       Date:  2017-06       Impact factor: 1.429

8.  Enhancing mHealth Technology in the Patient-Centered Medical Home Environment to Activate Patients With Type 2 Diabetes: A Multisite Feasibility Study Protocol.

Authors:  Ronald Gimbel; Lu Shi; Joel E Williams; Cheryl J Dye; Liwei Chen; Paul Crawford; Eric A Shry; Sarah F Griffin; Karyn O Jones; Windsor W Sherrill; Khoa Truong; Jeanette R Little; Karen W Edwards; Marie Hing; Jennie B Moss
Journal:  JMIR Res Protoc       Date:  2017-03-06

9.  Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine.

Authors:  Mahmoud Radwan; Aymen Elsous; Hasnaa Al-Sharif; Ayman Abu Mustafa
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-05       Impact factor: 3.565

10.  Predictors of Glycated Hemoglobin among Jordanian Diabetic Patients.

Authors:  Sawsan Hammad; Muhammad Darawad; Eman Hourani; Waddah Demeh
Journal:  Iran J Public Health       Date:  2015-11       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.